NCCS Joins Letter Expressing “Serious Reservations” About “Right to Try” Legislation

NCCS joined with colleagues in the Cancer Leadership Council to express serious reservations about proposed “right to try” legislation that will remove the Food and Drug Administration (FDA) from the approval process for patient access to an investigational therapy outside a clinical trial. NCCS does not believe that right to try legislation removing FDA from … Continue reading NCCS Joins Letter Expressing “Serious Reservations” About “Right to Try” Legislation